Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
@article{PCM5616,
author = {Kartik Sehgal and Andrew J. Piper-Vallillo and Hollis Viray and Adeel M. Khan and Deepa Rangachari and Daniel B. Costa},
title = {Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?},
journal = {Precision Cancer Medicine},
volume = {3},
number = {0},
year = {2020},
keywords = {},
abstract = {},
issn = {2617-2216}, url = {https://pcm.amegroups.org/article/view/5616}
}